Granulocyte Colony-Stimulating Factor (G-CSF)

BreastfeedingPediatric
  • TRADE NAMES: Filgrastim; Granix (Sicor); Grasin; Leucogen; Leukine (Bayer, Berlex); Neulasta (Amgen); Neupogen (Amgen); Neupogen 30; Prokine; Zarxio (Novartis)
  • INDICATIONS: Bone marrow allograft and autograft
  • SYNONYM: filgrastim; sargramostim
  • CLASS: Colony stimulating factor, Hematopoietic
  • HALF-LIFE: filgrastim: 3.5 hours; sargramostim: 2–3 hours; pegfilgrastim: 15–80 hours; tbo-filgrastim: 3–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Fluorouracil

PREGNANCY CATEGORY: C

rGM-CSF is granulocyte-macrophage colony-stimulating factor; rG-CSF is granulocyte colony-stimulating factor.

Our database has 116 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
RENAL
HEMATOLOGIC
OTIC
OCULAR
LOCAL
OTHER


Page last updated 09/25/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric